IRIS
FILLA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.031
NA - Nord America 11.229
EU - Europa 8.156
SA - Sud America 1.462
AF - Africa 307
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 7
Totale 33.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.759
SG - Singapore 5.398
RU - Federazione Russa 3.758
VN - Vietnam 2.206
CN - Cina 2.091
BR - Brasile 1.175
IT - Italia 1.156
HK - Hong Kong 1.078
DE - Germania 542
NL - Olanda 500
FI - Finlandia 461
FR - Francia 437
UA - Ucraina 340
CA - Canada 286
GB - Regno Unito 260
JP - Giappone 250
IN - India 231
IE - Irlanda 220
BD - Bangladesh 143
SE - Svezia 131
AR - Argentina 119
MX - Messico 113
ZA - Sudafrica 95
IQ - Iraq 89
ES - Italia 72
PL - Polonia 64
AT - Austria 61
PH - Filippine 60
TH - Thailandia 54
KR - Corea 53
CI - Costa d'Avorio 50
TR - Turchia 48
ID - Indonesia 44
EC - Ecuador 40
PK - Pakistan 40
TW - Taiwan 36
CO - Colombia 30
VE - Venezuela 25
BE - Belgio 22
IL - Israele 22
LT - Lituania 22
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 20
KE - Kenya 20
CL - Cile 19
NP - Nepal 19
EG - Egitto 18
MA - Marocco 18
ET - Etiopia 16
PY - Paraguay 16
UY - Uruguay 15
AZ - Azerbaigian 14
CZ - Repubblica Ceca 14
IR - Iran 14
RO - Romania 14
TN - Tunisia 14
AU - Australia 13
JO - Giordania 13
LB - Libano 13
SA - Arabia Saudita 13
DZ - Algeria 12
PT - Portogallo 12
BG - Bulgaria 11
MY - Malesia 11
BO - Bolivia 10
CR - Costa Rica 10
MU - Mauritius 10
JM - Giamaica 9
PE - Perù 9
AL - Albania 8
GR - Grecia 8
TT - Trinidad e Tobago 8
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
PS - Palestinian Territory 7
SN - Senegal 7
CH - Svizzera 6
PA - Panama 6
CU - Cuba 5
DK - Danimarca 5
EE - Estonia 5
BB - Barbados 4
CG - Congo 4
GT - Guatemala 4
HU - Ungheria 4
LV - Lettonia 4
MK - Macedonia 4
UG - Uganda 4
AM - Armenia 3
AO - Angola 3
BW - Botswana 3
BZ - Belize 3
CM - Camerun 3
DM - Dominica 3
EU - Europa 3
GA - Gabon 3
HN - Honduras 3
LK - Sri Lanka 3
NG - Nigeria 3
NO - Norvegia 3
Totale 33.123
Salva come PNG Salva come JPEG
Città #
Singapore 2.425
San Jose 1.551
Hong Kong 1.037
Chandler 1.000
Ashburn 906
Moscow 902
Ho Chi Minh City 602
Beijing 594
Hanoi 509
Santa Clara 423
Amsterdam 418
Millbury 411
Princeton 342
The Dalles 331
Jacksonville 323
Lauterbourg 302
Los Angeles 273
Nanjing 254
Naples 244
Tokyo 220
Dallas 212
Boston 191
Buffalo 153
New York 151
Wilmington 141
Redondo Beach 126
Hefei 118
Ottawa 118
Munich 113
São Paulo 108
Da Nang 96
Nanchang 96
Napoli 86
Council Bluffs 85
Seattle 83
Haiphong 74
Des Moines 65
Frankfurt am Main 65
Turku 65
Chicago 61
Dong Ket 60
Norwalk 58
Orem 58
London 52
Mexico City 52
Toronto 52
Warsaw 52
Atlanta 51
Houston 51
Montreal 50
Tianjin 50
Chennai 49
Helsinki 49
Johannesburg 49
Brooklyn 48
Nuremberg 48
Rome 48
Shenyang 48
Jiaxing 47
Woodbridge 47
Denver 46
Hebei 45
Rio de Janeiro 45
Milan 43
Redwood City 40
Poplar 36
Hải Dương 35
Falls Church 34
Nola 34
Biên Hòa 31
Washington 31
Changsha 29
Columbus 29
Stockholm 29
Vienna 29
Belo Horizonte 28
Can Tho 27
Phoenix 27
Boardman 25
Kunming 25
Manchester 25
Curitiba 24
San Francisco 24
Baghdad 23
Kronberg 23
Mumbai 23
San Mateo 23
Ankara 22
Dublin 22
Lawrence 21
Tashkent 21
Augusta 20
Falkenstein 20
Porto Alegre 20
Bangkok 19
Cape Town 19
Ninh Bình 19
Shanghai 19
Charlotte 18
New Delhi 18
Totale 17.384
Salva come PNG Salva come JPEG
Nome #
GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response 298
Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. 242
SISTEMA NERVOSO. Neurologia - Neurochirurgia - Neuroradiologia 239
Insulin Sensitivity and Early-Phase Insulin Secretion in Normoglycemic Huntington's Disease Patients 224
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 202
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 182
Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. 180
Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit. 176
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. 175
Ataxia-myoclonus syndrome due to a novel homozygous ATP13A2 mutation 172
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 170
Modifications of resting state networks in spinocerebellar ataxia type 2 167
Cognitive and functional connectivity alterations in Friedreich's ataxia 162
Benign hereditary chorea: clinical and neuroimaging features in an Italian family. 161
SPG5 and multiple sclerosis: clinical and genetic overlap? 159
Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study 158
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 157
Chronic Pachymeningitis: a case of neurosyphilis with spastic paraparesis. 155
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 155
Influence of GAA expansion size and disease duration on Central Nervous System impairment in Friedreich's Ataxia. Contribution to the understanding of the pathophysiology of the disease 154
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 154
‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab 154
Cerebellar blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 152
Pathological laughter as onset symptom in atypical parkinsonisms 152
Ataxia with oculomotor apraxia type 1 in southern italy: late onset and variable phenotype. 151
Default-Mode Network Changes in Huntington's Disease: An Integrated MRI Study of Functional Connectivity and Morphometry. 151
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis 150
Safety and feasibility of upper limb cardiopulmonary exercise test in Friedreich ataxia 150
Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer's disease? 148
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C 147
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 147
Variable phenotype in a P102L Gerstmann-Straussler-Scheinker Italian family 146
Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia 144
Complex phenotype in an Italian family with a novel mutation in SPG3A. 144
Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients 143
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 143
Predictors of survival in spinocerebellar ataxia type 2 population from Southern Italy. 143
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. 142
Longitudinal study of a cohort of MSA-C patients in South Italy: survival and clinical features 142
Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype 141
Spinocerebellar ataxia type 48: last but not least 141
Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells. 140
Be aware of Wolfram syndrome when examining ataxic patients 140
Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families 139
Very late onset in ataxia oculomotor apraxia type I. 139
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 139
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 138
Peripheral markers of autophagy in polyglutamine diseases 138
Adult normative values for the PATA Rate Test 138
Electrophysiologic characterization in spinocerebellar ataxia 17 137
MRI analysis of two cases of cerebrotendinous xanthomathosis (Studio RM di due casi di xantomatosi cerebro-tendinea) 136
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study 135
Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. 135
Recombinant human erythropoietin increasesfrataxin protein expression without increasing mRNA expression 135
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy 135
Reversible valproate-induced subacute encephalopathy associated with a MT-ATP8 variant in the mitochondrial genome 134
PPAR-gamma Agonist Azelaoyl PAF Increases Frataxin Protein and mRNA Expression. New Implications for the Friedreich's Ataxia Therapy 133
Aprataxin 133
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. 133
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 133
DNA damage induced by polyglutamine-expanded proteins. 132
Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. 131
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. 131
Degenerative and acquired sporadic adult onset ataxia 131
The complex phenotype of spinocerebellar ataxia type 48 in eight unrelated Italian families 131
Percutaneous stimulation of mechanoreceptors and peripheral neural transmission in normal subjects and patients with hereditary ataxias. 130
Somatosensory Temporal Discrimination Threshold Is Increased in Patients with Cerebellar Atrophy. 130
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia 130
Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay 129
Eculizumab improves fatigue in refractory generalized myasthenia gravis 129
Consistent improvement with eculizumab across muscle groups in myasthenia gravis 129
Variable phenotype in a P102L Gerstmann-Sträussler-Scheinker Italian family. 128
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A 127
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 127
A randomized clinical trial of lithium in multiple system atrophy. 127
The Effect of Cerebellar Degeneration on Human Sensori-motor Plasticity 127
Spinocerebellar ataxia type 2-neuronopathy or neuropathy? 127
Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families 127
Friedreich's disease. A linkage study in southern andcentral Italy. 125
Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation. 125
Metabolic Ataxias in Adults. 125
A genetic study of Parkinson's disease. 123
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study 123
New AARS2 Mutations in Two Siblings With Tremor, Downbeat Nystagmus, and Primary Amenorrhea: A Benign Phenotype Without Leukoencephalopathy 123
DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich's ataxia patients. 122
A novel mutation in GCH-1 gene in a case of dopa-responsive dystonia. 122
A double-blind, cross-over trial with madopar HBS in patients with Parkinson's disease. 121
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension 120
The Multiple Faces of Spinocerebellar Ataxia type 2 120
SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. 119
Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome. 119
Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. 119
Screening for RFC-1 pathological expansion in late-onset ataxias: a contribution to the differential diagnosis. 119
Le atassie ereditarie 118
INTERGENERATIONAL INSTABILITY AND MARKED ANTICIPATION IN SCA-17. 117
A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. 117
Of cognition and cerebellum in SCA48 117
Paroxysmal dystonia in Behcet's disease. 116
Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation. 116
A Novel PSEN1 Mutation in a Patient with Sporadic Early-Onset Alzheimer's Disease and Prominent Cerebellar Ataxia. 116
Totale 14.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.417
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.934 50 37 30 34 22 68 32 97 241 158 301 864
2022/20232.398 415 202 52 209 271 242 5 164 310 398 102 28
2023/20241.553 51 209 220 99 64 111 21 299 6 35 325 113
2024/20258.550 496 537 42 59 204 345 884 587 827 848 2.955 766
2025/202615.437 1.864 991 1.483 1.431 2.736 693 1.693 954 1.942 1.018 332 300
2026/2027396 396 0 0 0 0 0 0 0 0 0 0 0
Totale 33.710